Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Periocular botulinum toxin.

Timothy Corcoran Flynn1

  • 1Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA. flynn@caryskincenter.com

Clinics in Dermatology
|February 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrastructural analysis of 3 hyaluronic acid soft-tissue fillers using scanning electron microscopy.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2015
Same author

Molecular weight analyses and enzymatic degradation profiles of the soft-tissue fillers Belotero Balance, Restylane, and Juvéderm Ultra.

Plastic and reconstructive surgery·2013
Same author

IncobotulinumtoxinA in esthetics.

Journal of drugs in dermatology : JDD·2013
Same author

Long-term results for incobotulinumtoxinA in the treatment of glabellar frown lines.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2012
Same author

Advances in the use of botulinum neurotoxins in facial esthetics.

Journal of cosmetic dermatology·2012
Same author

Comparative histology of intradermal implantation of mono and biphasic hyaluronic acid fillers.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2011

Botulinum toxin type A, commonly known as BOTOX, has transformed cosmetic treatments for eye wrinkles. It is the most popular cosmetic procedure in the United States, with FDA approval for glabellar lines.

Area of Science:

  • Dermatology
  • Cosmetic Surgery

Background:

  • Botulinum toxin type A has significantly advanced the field of cosmetic dermatology.
  • Its efficacy in treating periorbital wrinkles was first documented by Drs. Jean and Alastair Carruthers.

Purpose of the Study:

  • To review the cosmetic applications and widespread adoption of Botulinum toxin type A.
  • To highlight its status as a leading cosmetic treatment.

Main Methods:

  • Literature review of published articles on the cosmetic use of Botulinum toxin type A.
  • Analysis of its regulatory approval and market popularity.

Main Results:

  • Botulinum toxin type A is widely recognized for its effectiveness in treating wrinkles around the eyes.

Related Experiment Videos

  • It has received U.S. Food and Drug Administration approval for glabellar lines.
  • It is the most popular cosmetic treatment in the United States.
  • Conclusions:

    • Botulinum toxin type A has revolutionized non-surgical cosmetic procedures.
    • Its established safety profile and efficacy have led to its global popularity and widespread use.